Editor-in-Chief Hatice Kübra Elçioğlu Vice Editors Levent Kabasakal Esra Tatar Online ISSN 2630-6344 Publisher Marmara University Frequency Bimonthly (Six issues / year) Abbreviation J.Res.Pharm. Former Name Marmara Pharmaceutical Journal
Marmara Pharmaceutical Journal 2017 , Vol 21 , Issue 2
Investigation of Inducible Clindamycin Resistance in Methicillin Resistant Staphylococcus Aureus Strains
Hayrunisa Hancı1,Ahmet Ayyıldız2,Hakan İgan3
1Atatürk University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology, 25240, Erzurum, Turkey
2Ataturk University, Medical Faculty, Department of Medical Microbiology, Erzurum, Turkey
3Palandöken State Hospital, Department of Microbiology, Erzurum, Turkey
DOI : 10.12991/marupj.301167 Clindamycin is one of the important alternative antibiotics in the therapy of Staphylococcus aureus infections. The limited treatment options for MRSA, increaes the importance of the right antibiotic.The major problem of the use of clindamycin for such infections is the presence of inducible clindamycin resistance that can lead to treatment failure. The aim of this study was to investigate the inducible clindamycin resistance of 86 MRSA strains isolated from Research Hospital of Ataturk University. Inducible clindamiycin resistance was detected using D zone test method according to Clinical and Laboratory Standards Institute (CLSI) instructions. Twenty of the strains exhibited the iMLSB, 8 exhibited the cMLSB and 22 exhibited the MS phenotype. The D zone test, which can be done by using erythromycin and clindamycin discs, is a simple disc diffusion test for detection MLSB phenotype and clinical laboratories should report in vitro inducible clindamycin resistance in all S. aureus isolates. Keywords : D zone test, Inducible clindamycin resistance, MRSA
Marmara University